Portantino Supports Legislator Pay Cut | Xencor B-Cell Medicine in Clinical Trials

~ Assemblyman Anthony Portantino, who represents part of Monrovia, said he would not object to a five percent pay cut for legislators. http://goo.gl/L05WK

~ Monrovia-based Xencor and Germany's MorphoSys AG have enrolled patient enrollment in the phase 1 clinical trial evaluating MOR208, an "anti-CD19 antibody with a proprietary modification to the Fc portion, that is being developed to treat B-cell malignancies."

- Brad Haugaard